Chembio Diagnostics, Inc. CEMI
We take great care to ensure that the data presented and summarized in this overview for CHEMBIO DIAGNOSTICS, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in CEMI
Top Purchases
Top Sells
About CEMI
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.
Insider Transactions at CEMI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 27
2023
|
Perceptive Credit Advisors, LLC |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
5,162,782
-100.0%
|
$0
$0.45 P/Share
|
|
Apr 26
2023
|
Paul Angelico |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
66,450
-100.0%
|
$0
$0.45 P/Share
|
|
Apr 26
2023
|
Katherine Lyon Davis |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
106,457
-100.0%
|
$0
$0.45 P/Share
|
|
Apr 26
2023
|
Charles Caso |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
34,674
-100.0%
|
$0
$0.45 P/Share
|
|
Apr 26
2023
|
Javan Esfandiari |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
145,612
-100.0%
|
$0
$0.45 P/Share
|
|
Apr 26
2023
|
John Gary Potthoff |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
54,086
-100.0%
|
$0
$0.45 P/Share
|
|
Apr 26
2023
|
David William Bespalko |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
11,469
-100.0%
|
$0
$0.45 P/Share
|
|
Apr 26
2023
|
Lawrence J. Steenvoorden |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
37,453
-100.0%
|
$0
$0.45 P/Share
|
|
Apr 26
2023
|
Richard Eberly |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
51,413
-100.0%
|
$0
$0.45 P/Share
|
|
Apr 26
2023
|
Richard Eberly |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
241,759
-100.0%
|
$0
$0.45 P/Share
|
|
Apr 26
2023
|
David Acheson |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
9,785
-100.0%
|
$0
$0.45 P/Share
|
|
Apr 25
2023
|
Perceptive Credit Advisors, LLC |
BUY
Open market or private purchase
|
Indirect |
133,742
+2.53%
|
$0
$0.45 P/Share
|
|
Apr 24
2023
|
Perceptive Credit Advisors, LLC |
BUY
Open market or private purchase
|
Indirect |
39,506
+0.78%
|
$0
$0.45 P/Share
|
|
Apr 21
2023
|
Perceptive Credit Advisors, LLC |
BUY
Open market or private purchase
|
Indirect |
70,200
+1.39%
|
$0
$0.45 P/Share
|
|
Apr 20
2023
|
Perceptive Credit Advisors, LLC |
BUY
Open market or private purchase
|
Indirect |
56,000
+1.13%
|
$0
$0.45 P/Share
|
|
Apr 19
2023
|
Perceptive Credit Advisors, LLC |
BUY
Open market or private purchase
|
Indirect |
137,000
+2.74%
|
$0
$0.45 P/Share
|
|
Apr 18
2023
|
Perceptive Credit Advisors, LLC |
BUY
Open market or private purchase
|
Indirect |
15,800
+0.33%
|
$0
$0.45 P/Share
|
|
Apr 17
2023
|
Perceptive Credit Advisors, LLC |
BUY
Open market or private purchase
|
Indirect |
4,800
+0.1%
|
$0
$0.45 P/Share
|
|
Apr 14
2023
|
Perceptive Credit Advisors, LLC |
BUY
Open market or private purchase
|
Indirect |
11,500
+0.24%
|
$0
$0.45 P/Share
|
|
Apr 13
2023
|
Perceptive Credit Advisors, LLC |
BUY
Open market or private purchase
|
Indirect |
140,134
+2.9%
|
$0
$0.45 P/Share
|